Divino Group co-founder Chris Knight served as a VP of Cohn & Wolfe's Global Tech Practice where he worked for 8+ years - including his role in helping to grow and manage business for major healthtech and biotech companies such as Genentech and McKesson in conjunction with GCI Health, which is consistently ranked among the best in the world in the sector - including being awarded as PRWeek's "Best Healthcare/Pharms Comms Agency" in the U.K. and a finalist in "Best Large Agency of the Year" by PRWeek in 2021. 

​

Since 2015, Divino Group has represented healthtech and biotech startups in Brazil, Mexico, and the U.S. including Finless Foods via Silicon Valley Latam Capital, Medsi, and Vittude via Redpoint eventures. Below you'll find some of the media coverage we have driven for these innovators.

 

For six months in 2016, our co-founder Chris Knight served as an interim communications director for Venrock, a Palo Alto, California-based VC firm formed in 1969 to build upon the successful investing activities of the Rockefeller family that began in the 1930s. Venrock specializes in investing in and helping to spur growth for biotech and healthtech innovators. 

​

​